Barclays PLC Acquires 164,821 Shares of GE HealthCare Technologies Inc. $GEHC

Barclays PLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,753,314 shares of the company’s stock after purchasing an additional 164,821 shares during the quarter. Barclays PLC owned about 0.38% of GE HealthCare Technologies worth $131,674,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Dodge & Cox increased its holdings in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. Norges Bank bought a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $468,120,000. Holocene Advisors LP lifted its holdings in shares of GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after acquiring an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. purchased a new position in GE HealthCare Technologies in the second quarter worth about $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in GE HealthCare Technologies during the second quarter valued at $58,388,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 3.7%

Shares of NASDAQ:GEHC opened at $74.27 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77. The business has a 50-day moving average price of $81.81 and a 200-day moving average price of $78.57. The stock has a market cap of $33.85 billion, a price-to-earnings ratio of 16.29, a PEG ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the previous year, the firm posted $1.45 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Analyst Ratings Changes

Several research firms recently commented on GEHC. Citigroup raised their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research report on Friday, January 9th. BTIG Research raised their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Bank of America lifted their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Finally, Jefferies Financial Group upped their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.